Company | SAPL | Symbol |
Company Name | Sanofi-Aventis Pakistan Limited | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 21.29 | Average of past year end EPS's |
Sector Average | Rs 19.85 | Sector average of the above |
Avg EPS FV | Rs 173.92 | Fair Value (DCF) based on average of past year end EPS's |
EPS | Rs 53.74 | Last four quarters EPS |
Sector Average | Rs 28.52 | Sector average of the above |
EPS FV | Rs 439.05 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 625.00 | Last closing stock price |
Updated | August 2013 | Data Month/Year |
Div | Rs 12.50 | Total dividend paid during last four quarters |
Sector Average | Rs 12.68 | Sector average of the above |
Div FV | Rs 102.12 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 6.15 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.44 | Sector average of the above |
Avg Div FV | Rs 50.25 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs 86.75 | Fair value (averaged of other fair values) |
Upside | -86.12% | Upside potential (in percentage) based on the above Average. |
Div Yield | 2.00% | Dividend yield |
Sector Average | 2.68% | Sector average of the above |
Book Value | Rs 181.55 | Book Value |
Sector Average | Rs 190.24 | Sector average of the above |
FV FCF/S | Rs -89.79 | Fair Value based on free cash flow per share |
Outstanding Shares | 9,644,800 | Number of Outstanding Shares |
Current Assets | Rs 3,920.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 3,682.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 24.68 | Net Current Asset Value / Share |
NNWC/S | Rs -187.79 | Net Net Working Capital / Share |
Total Assets | Rs 5,433.00 | Currency in Millions of Pakistan Rupees |
Quarter | September 2012 | Data Quarter |
CfO | Rs 21.00 | CASH FROM OPERATIONS (Millions of Rs) |
FCF/S | Rs -10.99 | Free Cash Flow per Share |
FCF/S Sector Avg | 14.79 | Sector Average FCF/S |
P/E | 11.63 | Price over earnings ratio |
P/E Sector Avg | 13.65 | Sector Average P/E |
P/B | 3.44 | Price over book value ratio |
P/B Sector Avg | 3.16 | Sector Average P/B |
PR | 23.26 | Payout Ratio (in %) |
PR Sector Avg | 37.01 | Sector average Payout Ratio (in %) |
D/E Ratio | 210.28 | Debt / Equite ratio (%) |
Sector D/E Ratio | 85.79 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 13/08/2013 | |
Last Trade Price | Rs 625.00 | |
3 Months Avg | Rs 481.12 | |
6 Months Avg | Rs 405.67 | |
9 Months Avg | Rs 335.32 | |
12 Months Avg | Rs 290.72 | |
Score | -18 | cumulative +ve's, -ve's from above all |
Buy Scale | -3 | Range -5 to +5 (based on 5 different complex analysis) |
Friday, August 23, 2013
SAPL - Sanofi-Aventis Pakistan Limited - Company Analysis - 23-08-2013
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment